Intel shares drop 2.9% as its 14A defect improvements are overshadowed by a $2.1 billion foundry division loss.

SANTA CLARA, California, August 30, 2026 — Intel Corporation (NASDAQ: INTC) shares fell 2.85% on Friday as investors weighed promising Intel 14A manufacturing data against a still-heavy foundry division loss.

The new data strengthen Intel’s technology narrative, though they do not yet prove profitable manufacturing at commercial scale. Chief Financial Officer David Zinsner noted that 14A defect density is tracking above Intel’s target curve, adding that the company has not seen comparable progress since 22nm Tom’s Hardware. Defect density measures imperfections per wafer area; a faster decline can support better yields, lower unit costs, and improved factory utilization. While it remains an early indicator, Intel plans to begin 14A risk production in the second half of 2027 and achieve high-volume manufacturing during 2028.

Customer interest is also becoming more concrete. According to Zinsner, outside discussions have shifted from examining technical data toward inquiring how much 14A capacity Intel could provide. The economics, however, remain difficult. Intel Foundry generated $5.77 billion in second-quarter revenue but recorded a $2.09 billion operating loss, per Intel results. That figure narrowed from $3.17 billion a year earlier, yet still equated to 36.2% of the segment’s quarterly revenue.

Intel’s product businesses continue to carry the investment burden. Data Center and AI revenue rose 59% to $6.3 billion, while client revenue increased 13% to $8.9 billion. Companywide revenue grew 25% to $16.1 billion. Non-GAAP gross margin reached 41.8%, and operating cash flow totaled $7 billion.

The High-NA EUV platform is central to the 14A roadmap. Intel states that the technology can print smaller features and increase pattern density compared with existing EUV systems.

Analyst sentiment remains cautious. Of the 50 tracked analysts, 16 rate the stock a buy, 31 hold, and three sell, with an average price target of $107.46, according to MarketBeat. Key risks include the fact that defect density does not directly equal production yield. Additionally, schedule slips, weak external demand, or high High-NA tool costs could delay any margin recovery.

Khadija Saeed is a financial markets reporter at TS2.tech. Her coverage spans stocks, technology, emerging industries, and developments across global markets. She studied economics and finance at the London School of Economics and worked in market research before transitioning to financial journalism. Readers can follow Khadija Saeed on Google News.